NVIV

InVivo Therapeutics Holdings Corporation (NVIV) | Rumor.io

InVivo Therapeutics Holdings

NVIV

Attention (50-day avg)0%

Attention rank (50-day avg)—

Bullish sentiment (50-day avg)—

Price to earnings ratio0

Market capitalization0

Earnings per share0

Dividend yield (TTM)—

Revenue (annual)0

Net income (annual)0

Social

What share of all stock conversation is about NVIV?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

Feb 9

InVivo Therapeutics Holdings Corporation ($NVIV) declined -11.98% in one day.
$NVIV has a float of 2.8M and a short interest of 0.8%.
The stock rallied 8.2% and is considered one to watch for potential further gains.

Generated by AI

Sentiment

Of the messages about NVIV that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	100% +26.67
Bearish	—	—	—	0% -26.67

Feb 6

$NVIV has shown significant price appreciation, increasing by over 300% on bad news and by up to 266% overall.
The company has a low float of 2.77 million shares, with a cash per share value of approximately $1.60, potentially leading to large price spikes before delisting.
$NVIV has a history of significant price movements, with a previous move of over 40% and a recent maxi trade, indicating potential for continued volatility.

Generated by AI

Topics

Of the messages about NVIV that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	—
Announcements	—	—	—	—
Controversies	—	—	—	—
Earnings	—	—	—	—
Macro	—	—	—	—
Technical Analysis	—	—	—	—

Earnings· Mar 12

InVivo Therapeutics Holdings Corporation ($NVIV) reported a loss of $0.13, beating consensus estimates of a loss of $0.16 per share.
The company's earnings per share (EPS) were less than expected, with a reported loss of $0.13 compared to the expected loss of $0.16.
This earnings beat may be attributed to the company's better-than-expected performance, as indicated by the $0.03 difference between the reported and expected loss per share.

Announcements· Feb 7

InVivo Therapeutics Holdings Corporation (NVIV) is trading higher amid volatility after filing for relief under Chapter 11.
InVivo Therapeutics Faces NASDAQ Delisting due to non-compliance with listing requirements.
InVivo Therapeutics' shares are near the top of equities by percentage gain on a specific date.

Generated by AI

Community

Of the messages about NVIV, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	—	0%
Newcomers	—	—	—	100%

Regulars· Feb 7

The use of AI trading programs by $NVIV in 2024 has led to increased volatility, with the stock experiencing a 300% price jump after hours and a subsequent dump.
The stock's price movement has been characterized by a high-risk, high-reward profile, with a 500% move higher in a short period.
The company's complete float of 2.8M shares has been traded in a single day, with 18.7M shares traded overall, indicating high liquidity and volatility.

Newcomers· Feb 7

The post discusses the breakout of NVIV on February 6th, highlighting its explosive push at the open and subsequent consolidation around the 9 EMA.
The post notes that NVIV lost the 21 EMA shortly after, but the author kept it on their watchlist due to the lack of major selling pressure.
The post mentions that NVIV shares are trading higher amid volatility after the company filed for relief under Chapter 11, citing the potential for momentum in the stock.

Generated by AI

Also Discussed

Investors talking about NVIV also mention

#	Name	Attention
1	SGLB - Sigma Labs, Inc.	——
2	ATHX - Athersys, Inc.	——
3	Geron CorporationGERN	0%0
4	BCLI - Brainstorm Cell Therapeutics Inc.	——
5	TTNP - Titan Pharmaceuticals, Inc.	——
6	Lipocine Inc.LPCN	0%new
7	Nicholas Bitcoin and Treasuries AfterDark ETFNGHT	0%0
8	XOMA CorporationXOMA	0%0
9	DRRX - DURECT Corporation	——
10	AcelRx Pharmaceuticals IncACRX	0%new